WCFA
GILD icon

Walkner Condon Financial Advisors’s Gilead Sciences GILD Stock Holding History

Walkner Condon Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$683K Buy
5,409
+1,278
+31% +$168K 0.08% 159
2026
Q1 		$576K Buy
4,131
+126
+3% +$17.6K 0.08% 158
2025
Q4 		$492K Buy
4,005
+64
+2% +$7.78K 0.07% 179
2025
Q3 		$437K Buy
3,941
+355
+10% +$40.4K 0.07% 189
2025
Q2 		$398K Buy
3,586
+103
+3% +$11K 0.07% 187
2025
Q1 		$390K Buy
3,483
+31
+0.9% +$3.2K 0.08% 179
2024
Q4 		$319K Buy
3,452
+56
+2% +$5.04K 0.06% 208
2024
Q3 		$285K Buy
3,396
+286
+9% +$21.8K 0.06% 219
2024
Q2 		$213K Buy
3,110
+38
+1% +$2.54K 0.05% 242
2024
Q1 		$225K Buy
3,072
+61
+2% +$4.69K 0.05% 248
2023
Q4 		$244K Buy
3,011
+87
+3% +$6.77K 0.06% 232
2023
Q3 		$219K Sell
2,924
-254
-8% -$19.5K 0.06% 227
2023
Q2 		$245K Buy
3,178
+343
+12% +$27.4K 0.06% 206
2023
Q1 		$235K Buy
2,835
+213
+8% +$17.6K 0.07% 206
2022
Q4 		$225K Buy
+2,622
New +$208K 0.07% 207

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Walkner Condon Financial Advisors's GILD Position: Q2 2026 in Review

Walkner Condon Financial Advisors increased its Gilead Sciences (GILD) stake by 31% in Q2 2026, buying an estimated $168K and bringing the position to 5,409 shares worth $683K. The position accounts for 0.08% of the portfolio, ranked #159.

Walkner Condon Financial Advisors first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Walkner Condon Financial Advisors held 5,409 shares of Gilead Sciences worth $683K as of Q2 2026.
  • Walkner Condon Financial Advisors bought 1,278 Gilead Sciences shares in Q2 2026, an estimated $168K.
  • Gilead Sciences made up 0.08% of Walkner Condon Financial Advisors's portfolio in Q2 2026, its #159 holding.
  • Walkner Condon Financial Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Walkner Condon Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.